9135699

Chapman IM

1997

Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters.

9136416

Kleppa A

1997

Infertility: a cycle of hope and disappointment.

9141511

Schipper I

1997

Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndrome.

9141522

Mesiano S

1997

Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation.

9141527

Ciaraldi TP

1997

Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity.

9145594

Kichukova D

1996

Polycystic ovaries in association with pelvic endometriosis in infertile women diagnosed by laparoscopy.

9147238

Cano F

1997

Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women.

9147642

Gharani N

1997

Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism.

9149440

Anderson E

1997

The polycystic ovarian (PCO) condition: apoptosis and epithelialization of the ovarian antral follicles are aspects of cystogenesis in the dehydroepiandrosterone (DHEA)-treated rat model.

9150702

Sahin Y

1997

Lack of relationship between 17-hydroxyprogesterone response to buserelin testing and hyperinsulinemia in polycystic ovary syndrome.

9160821

Villa P

1997

Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients.

9164062

Timpatanapong P

1997

Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.

9165655

Wild RA

1997

Metabolic aspects of polycystic ovary syndrome.

9165656

Nestler JE

1997

Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.

9165657

Cataldo NA

1997

Insulin-like growth factor binding proteins: do they play a role in polycystic ovary syndrome?

9165658

Gonzalez F

1997

Adrenal involvement in polycystic ovary syndrome.

9165659

Barnes RB

1997

Pathophysiology of ovarian steroid secretion in polycystic ovary syndrome.

9165660

Berga SL

1997

Can polycystic ovary syndrome exist without concomitant hypothalamic dysfunction?

9165661

Morales AJ

1997

Role of growth hormone in polycystic ovarian syndrome.

9165662

Shanti A

1997

Surgical approaches to ovulation induction.

9165663

Kazer RR

1997

Lecturing on polycystic ovary syndrome (PCOS)

9166386

Morgan JF

1997

Polycystic ovary syndrome.

9166393

Zamberlan N

1997

Intermittent Etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist.

9167914

Smolar EN

1997

The insulin resistance syndrome.

9174750

Barnes RB

1997

Polycystic ovarian disease.

9174850

Ellenbogen A

1997

The behavior of follicle cysts formed after long-acting gonadotropin-releasing hormone analog administration in patients with polycystic ovarian syndrome.

9174851

Battaglia C

1997

Color Doppler analysis in oligo- and amenorrheic women with polycystic ovary syndrome.

9174852

Jahanfar S

1997

A twin study of polycystic ovary syndrome and lipids.

9177363

Caro JF

1997

Leptin is normal in PCOS, an editorial about three negative papers.

9177364

Mantzoros CS

1997

Leptin concentrations in the polycystic ovary syndrome.

9177365

Laughlin GA

1997

Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.

9177366

Rouru J

1997

Serum leptin concentrations in women with polycystic ovary syndrome.

9177373

Mullis PE

1997

Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood.

9177410

Pigny P

1997

Serum alpha-inhibin levels in polycystic ovary syndrome: relationship to the serum androstenedione level.

9177424

Rosner W

1997

Errors in the measurement of plasma free testosterone.

9186269

Fridstr?m M

1997

Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin.

9193402

McKeigue P

1997

Association of insulin gene VNTR polymorphism with polycystic ovary syndrome.

9194637

Carmina E

1997

Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.

9194638

Sahin Y

1997

17-Hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17alpha dysregulation.

9194647

Salha O

1997

Endometrial carcinoma in a young patient with polycystic ovarian syndrome: first suspected at time of embryo transfer.

9197039

Khoury MY

1996

Polycystic ovary syndrome: clinical and laboratory evaluation.

9206181

Li R

1996

[Fertilization in vitro and embryo transfer by combined long-acting gonadotropin releasing hormone agonist and gonadotropin for superovulation in patients with refractory polycystic ovary syndrome].

9210846

Tait DL

1997

Multicystic ovarian tumor weighing 156 lbs: the second largest tumor in Texas.

9211124

Liovi? M

1997

CYP17 gene analysis in hyperandrogenised women with and without exaggerated 17-hydroxyprogesterone response to ovarian stimulation.

9211130

Tropeano G

1997

Effects of ovary suppression by a long-acting GnRH-agonist on circulating GH, insulin-like growth factor I and insulin levels in women with polycystic ovary syndrome.

9212768

Magrina JF

1997

Office management of ovarian cysts.

9215280

Ehrmann DA

1997

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.

9215302

Taylor AE

1997

Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.

9215494

Yong EL

1997

Responses of polycystic ovarian syndrome and related variants to low-dose follicle stimulating hormone.

9219117

Rojansky N

1997

Polycystic ovary syndrome. An autoimmune disease?

9221990

Buyalos RP

1997

Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.

9221993

Cheung AP

1997

Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.

9231809

Risma KA

1997

Elevated luteinizing hormone in prepubertal transgenic mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology.

9237079

Yoshimura Y

1997

The ovarian renin-angiotensin system in reproductive physiology.

9238253

Mastorakos G

1997

Autocrine-paracrine role of ovarian corticotropin-releasing hormone.

9238268

Diamanti-Kandarakis E

1997

The polycystic ovary syndrome. Pathogenesis, metabolic implications, and therapeutic approach.

9238269

Dramusic V

1997

Adolescent polycystic ovary syndrome.

9240249

Valentino R

1997

Different dysregulations in adrenal steroid biosynthesis as a prevalent cause of hyperandrogenism in women from southern Italy.

9240258

Chen CD

1997

Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome.

9246840

Pettigrew R

1997

Obesity and female reproductive function.

9246962

Colacurci N

1997

In vitro fertilization following laparoscopic ovarian diathermy in patients with polycystic ovarian syndrome.

9262275

Rimington MR

1997

The use of laparoscopic ovarian electrocautery in preventing cancellation of in-vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries.

9263703

Barth JH

1997

Investigations in the assessment and management of patients with hirsutism.

9263704

Prelevic GM

1997

Insulin resistance in polycystic ovary syndrome.

9269124

Paternoster D

1997

Polycystic ovarian syndrome and pregnancy.

9269346

Ho SP

1997

Endometrial hyperplasia and the risk of endometrial carcinoma.

9269382

Au Eong KG

1997

Idiopathic intracranial hypertension, empty sella turcica and polycystic ovary syndrome--a case report.

9272421

Falsetti L

1997

Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.

9272422

Grochowski D

1997

The outcome of an in vitro fertilization program in women with polycystic ovary syndrome.

9277650

Vel?zquez E

1997

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

9279164

Franks S

1997

Polycystic ovary syndrome.

9279941

Bosinski HA

1997

A higher rate of hyperandrogenic disorders in female-to-male transsexuals.

9283803

Bloomgarden ZT

1997

Topics in type 2 diabetes.

9284012

Urman B

1997

Pregnancy in infertile PCOD patients. Complications and outcome.

9286726

Rousso D

1997

Suppression of serum prolactin levels after an oral glucose tolerance test in patients with polycystic ovarian syndrome.

9288656

Dramusic V

1997

Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents.

9289801

Imthurn B

1997

[Pathogenesis and diagnosis of androgenetic manifestations].

9289973

P?rez Guti?rrez JF

1996

[New arguments with respect to the physiopathology of the polycystic ovary syndrome].

9291006

Lehtinen JC

1997

Visualization of clinical data with neural networks, case study: polycystic ovary syndrome.

9294648

Anderson E

1997

Polycystic ovarian condition in the dehydroepiandrosterone-treated rat model: hyperandrogenism and the resumption of meiosis are major initial events associated with cystogenesis of antral follicles.

9296913

Svacina S

1997

[Insulin, steroids and steroidogenesis].

9302378

Gilling-Smith C

1997

Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome.

9302393

Gdansky E

1997

Increased number of IGF-I receptors on erythrocytes of women with polycystic ovarian syndrome.

9304045

Scarpitta AM

1997

[Etiopathogenetic aspects and clinical implications of insulin resistance in polycystic ovary syndrome].

9308787

Kung FT

1997

Conservative management of early endometrial adenocarcinoma with repeat curettage and hormone therapy under assistance of hysteroscopy and laparoscopy.

9309459

Dumesic DA

1997

Estimated prevalence of undiagnosed glucose intolerance from hyperandrogenic anovulation among women requesting electrolysis.

9309461

Pellicano M

1997

Controlled ovarian hyperstimulation: comparison between u-hFSH conventional protocol and a personalized approach.

9313010

McBride NM

1997

Polycystic ovaries and coronary artery disease.

9314015

Henry RR

1997

Thiazolidinediones.

9314918

Holst N

1997

Regulation of insulin-like growth factor-binding protein-1 and progesterone secretion from human granulosa-luteal cells: effects of octreotide and insulin.

9317194

Parazzini F

1997

Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa.

9322100

Messinis IE

1997

Current and future status of ovulation induction in polycystic ovary syndrome.

9329374

Rajkhowa M

1997

Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.

9330669

Chen BY

1997

Acupuncture normalizes dysfunction of hypothalamic-pituitary-ovarian axis.

9342471

Panidis D

1997

Does postprandial hypersinsulinemia contribute to hyperandrogenism in patients with polycystic ovary syndrome?

9343501

Cresswell JL

1997

Fetal growth, length of gestation, and polycystic ovaries in adult life.

9347500

Hattab FN

1997

Oligodontia of the permanent dentition in two sisters with polycystic ovarian syndrome: case reports.

9360193

Lesser KB

1997

Association between polycystic ovary syndrome and glucose intolerance during pregnancy.

9360532

Arroyo A

1997

Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.

9363701

Pierro E

1997

Further evidence of increased aromatase activity in granulosa luteal cells from polycystic ovary.